These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 17287166

  • 1. Ruptured hepatocellular carcinoma following chemoembolization: a western experience.
    Battula N, Srinivasan P, Madanur M, Chava SP, Priest O, Rela M, Heaton N.
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):49-51. PubMed ID: 17287166
    [Abstract] [Full Text] [Related]

  • 2. Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization.
    Liu CL, Ngan H, Lo CM, Fan ST.
    Br J Surg; 1998 Apr; 85(4):512-4. PubMed ID: 9607536
    [Abstract] [Full Text] [Related]

  • 3. Emergency embolization in the treatment of ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization.
    Sun JH, Wang LG, Bao HW, Lou JL, Cai LX, Wu C, Chen LM, Zheng SS.
    Hepatogastroenterology; 2010 Apr; 57(99-100):616-9. PubMed ID: 20698237
    [Abstract] [Full Text] [Related]

  • 4. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
    Kimura S, Okazaki M, Higashihara H, Haruno M, Nozaki Y, Urakawa H, Kora S, Shinagawa Y, Nonokuma M.
    Hepatogastroenterology; 2009 Apr; 56(89):191-8. PubMed ID: 19453056
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.
    Kim JY, Lee JS, Oh DH, Yim YH, Lee HK.
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):640-5. PubMed ID: 22395224
    [Abstract] [Full Text] [Related]

  • 6. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
    Shen H, Agarwal D, Qi R, Chalasani N, Liangpunsakul S, Lumeng L, Yoo H, Kwo P.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):393-400. PubMed ID: 17635374
    [Abstract] [Full Text] [Related]

  • 7. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA.
    J Hepatol; 2006 Jan 01; 44(1):158-66. PubMed ID: 16290309
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Jan 01; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 9. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 01; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 10. Chemoembolization in patients at high risk: results and complications.
    Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA.
    J Vasc Interv Radiol; 2006 Jan 01; 17(1):47-53. PubMed ID: 16415132
    [Abstract] [Full Text] [Related]

  • 11. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
    Park JW, Park KW, Cho SH, Park HS, Lee WJ, Lee DH, Kim CM.
    Am J Gastroenterol; 2005 Oct 01; 100(10):2194-200. PubMed ID: 16181368
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A, Farinati F.
    Am J Gastroenterol; 2008 Apr 01; 103(4):914-21. PubMed ID: 18177453
    [Abstract] [Full Text] [Related]

  • 13. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.
    Huang J, He X, Lin X, Zhang C, Li J.
    Chin Med J (Engl); 2000 May 01; 113(5):446-8. PubMed ID: 11776102
    [Abstract] [Full Text] [Related]

  • 14. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.
    Cancer; 2009 Nov 15; 115(22):5132-8. PubMed ID: 19672999
    [Abstract] [Full Text] [Related]

  • 15. Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.
    Poggi G, Pozzi E, Riccardi A, Tonini S, Montagna B, Quaretti P, Tagliaferri B, Sottotetti F, Baiardi P, Pagella C, Minoia C, Bernardo G.
    Anticancer Res; 2010 Dec 15; 30(12):5159-64. PubMed ID: 21187505
    [Abstract] [Full Text] [Related]

  • 16. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S, Matsumoto S, Hamasaki K, Takatsuki M, Hidaka M, Tajima Y, Sakamoto I, Kanematsu T.
    J Hepatobiliary Pancreat Surg; 2008 Dec 15; 15(6):627-33. PubMed ID: 18987934
    [Abstract] [Full Text] [Related]

  • 17. Ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization.
    Bruls S, Joskin J, Chauveau R, Delwaide J, Meunier P.
    JBR-BTR; 2011 Dec 15; 94(2):68-70. PubMed ID: 21699037
    [Abstract] [Full Text] [Related]

  • 18. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH, Choi MS, Choi YS, Kim DY, Lee JM, Paik SW, Lee JH, Koh KC, Yoo BC, Choi D, Rhee JC.
    Korean J Hepatol; 2006 Mar 15; 12(1):55-64. PubMed ID: 16565606
    [Abstract] [Full Text] [Related]

  • 19. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP, Hu DY, Zhang ZW, Zhang BX, Chen YF, Zhang WG, Qiu FZ.
    Dig Surg; 2007 Mar 15; 24(3):208-13. PubMed ID: 17522469
    [Abstract] [Full Text] [Related]

  • 20. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.